Create an Account
  1. Home
  2. Specialty
  3. Cataract & Refractive

A Taste of the Roarin’ 20s: Prohibiting Cataract Complications

A Taste of the Roarin 20s Prohibiting Cataract Complications
Media formats available:
Details
Presenters

  • Overview

    White and ultrabrunescent cataracts pose multiple challenges for phaco surgeons. An expert faculty discuss advanced capsulotomy techniques, phaco pearls for the rock-hard lens, phacodynamics for brunescent nuclei, and managing common comorbidities such as small pupils and zonulopathy.

    Watch Program Chair David F. Chang, MD; Jason J. Jones, MD; Sumitra Khandelwal, MD;Jeff Pettey, MD, MBA, and Steven D. Vold, MD, as they partake in interactive case discussions on managing complex cataract extraction using the latest phaco techniques and technologies that can help you achieve better outcomes and improve patient care.

    This activity is supported by unrestricted educational grants from Johnson & Johnson Vision, Bausch + Lomb, and Carl Zeiss Meditec.

     

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Determine, customize, and modify phaco settings to maximize outcomes for complex cataract cases, and review the need to alter settings as necessary. 
    • Analyze the key unique details of phacoemulsification functions in peristaltic and venturi pumps, fluidics and phaco power modulation, as well as techniques for nuclear disassembly and hydrodissection in complex cataract cases.
    • Review key pearls for femtosecond rhexis creation, laser cataract nuclear disassembly, and unique considerations for extraction of emulsified lens material.

    • Accreditation

      Jointly Provided by Evolve Medical Education and The Fundingsland Group.

                 

      Accreditation Statement
      This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC (Evolve) and The Fundingsland Group. Evolve is accredited by the ACCME to provide continuing medical education for physicians.

      Credit Designation Statement
      Evolve Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.

    • Faculty and Disclosures

      David F. Chang, MD

      David F. Chang, MD

      Clinical Professor
      Department of Ophthalmology
      University of California, San Francisco
      Los Altos, CA


      Jason J. Jones, MD

      Jason J. Jones, MD

      Medical Director

      Jones Eye Clinic

      Sioux City, IA


      Sumitra Khandelwal, MD

      Sumitra Khandelwal, MD

      Associate Professor of Ophthalmology 

      Medical Director, Lions Eye Bank of Texas

      Baylor College of Medicine

      Houston, TX


      Jeff Pettey, MD, MBA

      Jeff Pettey, MD, MBA

      Vice Chair of Education

      John A. Moran Eye Center

      Associate Professor

      Department of Ophthalmology 

      and Visual Sciences

      University of Utah

      Salt Lake City, UT


      Steven D. Vold, MD

      Steven D. Vold, MD

      Vold Vision
      Fayetteville, AR


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      David F. Chang, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Beyeonics, Carl Zeiss Meditec, Centricity, Forsight Robotics, ForSight V6, Iantrek, iDrops, Johnson & Johnson Vision, JelliSee Ophthalmics, Longbridge Medical, Orasis Pharmaceuticals, Perfect Lens, RxSight, Surface, and Viewpoint. Stock/Shareholder: Beyeonics, Centricity, Eyenovia, Forsight Robotics, ForSight V6, Iantrek, iDrops, JelliSee Ophthalmics, Longbridge Medical, Orasis Pharmaceuticals, Perfect Lens, RxSight, Slack, Surface, and Viewpoint.

      Jason J. Jones, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon/Ivantis, Johnson & Johnson Vision, and Perfect Lens. Speaker's Bureau: Alcon/Ivantis, Johnson & Johnson Vision, and Slack.

      Sumitra Khandelwal, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch + Lomb, and Carl Zeiss Meditec.

      Jeff Pettey, MD, MBA, has had no financial relationships with ineligible companies.

      Steven D. Vold, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Aerie Pharmaceuticals, Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Glaukos, Iridex, istar Medical, Ivantis, Lumenis, and Volk Optical. Grant/Research Support: Alcon, Allergan, Aerie Pharmaceuticals, Bausch + Lomb, Carl Zeiss Meditec, Glaukos, Ivantis, O3 Optix, RxSight, Santen, and Sight Sciences. Stock/Shareholder: Alphaeon, Ivantis, O3 Optix, and OSRX.

      The Evolve and The Fundingsland Group staff and planners have no financial relationships with ineligible companies.
      Nisha Mukherjee, MD, peer reviewer, has no financial relationships with ineligible companies.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, Johnson & Johnson Vision, Bausch + Lomb, or Carl Zeiss Meditec.

      This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    LIVE ON REACHMD RADIOBack to live radio
    ReachMD Radio

    Loading...

    00:00
    00:00
      Register

      We're glad to see you're enjoying Evolve Medical Education…
      but how about a more personalized experience?

      Register for free